Lipoprotein (a)[Lp (a)] is a human plasma lipoprotein with unique structural and functional
characteristics. Lp (a) is an assembly of two components: a central core with apoB and an …

Abstract Lipoprotein (a)(Lp (a)) is associated with atherothrombosis through several
mechanisms, including putative antifibrinolytic properties. However, genetic association …

Lipoprotein (a)[Lp (a)] resembles low-density lipoprotein (LDL), with an LDL lipid core and
apolipoprotein B (apoB), but contains a unique apolipoprotein, apo (a). Elevated Lp (a) is an …

Lipoprotein (a) forms a subfraction of the lipid profile and is characterized by the addition of
apolipprotein (a)(apo (a)) to apoB100 derived particles. Its levels are mostly genetically …

Lipoprotein (a) has been implicated with an increased risk of atherosclerosis and
cardiovascular disease. Recently, considerable progress has been made toward …

Initially, lipoprotein (a)[Lp (a)] was believed to be a genetic variant of lipoprotein (Lp)-B.
Because its lipid moiety is almost identical to LDL, Lp (a) has been deliberately considered …

Recently published epidemiological and genetic studies strongly suggest a causal
relationship of elevated concentrations of lipoprotein (a)[Lp (a)] with cardiovascular disease …

Epidemiological and clinical studies over the past decade have firmly established that
elevated plasma concentrations of lipoprotein (a)(Lp (a)) are an important, independent and …

Lipoprotein(a): novel target and emergence of novel therapie... : Current Opinion in
Endocrinology, Diabetes and Obesity Lipoprotein(a): novel target and emergence of novel …

There is compelling evidence that the elevated plasma lipoprotein (a)[Lp (a)] levels increase
the risk of atherosclerotic cardiovascular disease (ASCVD) in the general population. Like …